Published in Am J Manag Care on February 01, 2013
Physician spending and subsequent risk of malpractice claims: observational study. BMJ (2015) 4.06
Hospital costs and inpatient mortality among children undergoing surgery for congenital heart disease. Health Serv Res (2013) 0.86
A population health approach to reducing observational intensity bias in health risk adjustment: cross sectional analysis of insurance claims. BMJ (2014) 0.84
Systematic review of the association between climate and hip fractures. Int J Biometeorol (2014) 0.81
Financial Implications of Hospital Readmission After Hip Fracture. Geriatr Orthop Surg Rehabil (2015) 0.76
Long-term impact of medicare payment reductions on patient outcomes. Health Serv Res (2014) 0.75
Costs and Consequences of Early Hospital Discharge After Major Inpatient Surgery in Older Adults. JAMA Surg (2017) 0.75
A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis (1987) 174.79
The implications of regional variations in Medicare spending. Part 1: the content, quality, and accessibility of care. Ann Intern Med (2003) 21.45
The implications of regional variations in Medicare spending. Part 2: health outcomes and satisfaction with care. Ann Intern Med (2003) 18.65
Use of electronic health records in U.S. hospitals. N Engl J Med (2009) 14.36
Does more intensive treatment of acute myocardial infarction in the elderly reduce mortality? Analysis using instrumental variables. JAMA (1994) 11.32
Assessing the sensitivity of regression results to unmeasured confounders in observational studies. Biometrics (1998) 8.48
Regional variations in diagnostic practices. N Engl J Med (2010) 7.44
Association between stroke center hospitalization for acute ischemic stroke and mortality. JAMA (2011) 3.68
Looking forward, looking back: assessing variations in hospital resource use and outcomes for elderly patients with heart failure. Circ Cardiovasc Qual Outcomes (2009) 2.80
Geographic variation in diagnosis frequency and risk of death among Medicare beneficiaries. JAMA (2011) 2.53
Association of hospital spending intensity with mortality and readmission rates in Ontario hospitals. JAMA (2012) 2.47
Is survival better at hospitals with higher "end-of-life" treatment intensity? Med Care (2010) 2.35
The pricing of U.S. hospital services: chaos behind a veil of secrecy. Health Aff (Millwood) (2006) 2.34
Use of Medicare claims data to monitor provider-specific performance among patients with severe chronic illness. Health Aff (Millwood) (2004) 2.33
Comparison of hospital risk-standardized mortality rates calculated by using in-hospital and 30-day models: an observational study with implications for hospital profiling. Ann Intern Med (2012) 1.90
Hospital spending and inpatient mortality: evidence from California: an observational study. Ann Intern Med (2011) 1.79
Is spending more always wasteful? The appropriateness of care and outcomes among colorectal cancer patients. Health Aff (Millwood) (2008) 1.70
Aggressive treatment style and surgical outcomes. Health Serv Res (2010) 1.66
Development and validation of hospital "end-of-life" treatment intensity measures. Med Care (2009) 1.58
Looking back, moving forward. N Engl J Med (2010) 1.30
The impact of leadership and quality climate on hospital performance. Int J Qual Health Care (2008) 1.23
Review: how do hospital organizational structure and processes affect quality of care?: a critical review of research methods. Med Care Res Rev (2007) 1.18
Evidence on the efficacy of inpatient spending on Medicare patients. Milbank Q (2010) 0.96
Medicare spending, mortality rates, and quality of care. Int J Health Care Finance Econ (2012) 0.89
Comment on Silber et al.: Investing in postadmission survival—a “failure-to-rescue” U.S. population health. Health Serv Res (2010) 0.86
Employer drug benefit plans and spending on prescription drugs. JAMA (2002) 6.02
Participation of patients 65 years of age or older in cancer clinical trials. J Clin Oncol (2003) 4.77
Differences in life expectancy due to race and educational differences are widening, and many may not catch up. Health Aff (Millwood) (2012) 4.36
Prespecified falsification end points: can they validate true observational associations? JAMA (2013) 3.11
Forecasting the nursing home population. Med Care (2003) 3.11
Trends in the earnings of male and female health care professionals in the United States, 1987 to 2010. JAMA Intern Med (2013) 2.97
Sexually transmitted diseases among users of erectile dysfunction drugs: analysis of claims data. Ann Intern Med (2010) 2.93
Why physicians work when sick. Arch Intern Med (2012) 2.65
On average, physicians spend nearly 11 percent of their 40-year careers with an open, unresolved malpractice claim. Health Aff (Millwood) (2013) 2.26
An analysis of whether higher health care spending in the United States versus Europe is 'worth it' in the case of cancer. Health Aff (Millwood) (2012) 2.16
The European Working Time Directive: an uncontrolled experiment in medical care and education. JAMA (2013) 2.10
Heterogeneity in action: the role of passive personalization in comparative effectiveness research. Health Econ (2013) 2.04
Substantial health and economic returns from delayed aging may warrant a new focus for medical research. Health Aff (Millwood) (2013) 2.03
Aging in America in the twenty-first century: demographic forecasts from the MacArthur Foundation Research Network on an Aging Society. Milbank Q (2009) 1.89
Are the young becoming more disabled? Health Aff (Millwood) (2004) 1.88
Confounding in the association of proton pump inhibitor use with risk of community-acquired pneumonia. J Gen Intern Med (2012) 1.83
Out-of-pocket medication costs and use of medications and health care services among children with asthma. JAMA (2012) 1.83
The health and cost consequences of obesity among the future elderly. Health Aff (Millwood) (2005) 1.79
Hospital spending and inpatient mortality: evidence from California: an observational study. Ann Intern Med (2011) 1.79
Growing Internet use may help explain the rise in prescription drug abuse in the United States. Health Aff (Millwood) (2011) 1.71
Impact of specialty drugs on the use of other medical services. Am J Manag Care (2008) 1.51
Three large-scale changes to the Medicare program could curb its costs but also reduce enrollment. Health Aff (Millwood) (2013) 1.50
U.S. pharmaceutical policy in a global marketplace. Health Aff (Millwood) (2008) 1.47
Cost sharing and the initiation of drug therapy for the chronically ill. Arch Intern Med (2009) 1.41
Drug licenses: a new model for pharmaceutical pricing. Health Aff (Millwood) (2008) 1.39
Patients value metastatic cancer therapy more highly than is typically shown through traditional estimates. Health Aff (Millwood) (2012) 1.38
Pharmacy benefit caps and the chronically ill. Health Aff (Millwood) (2007) 1.28
Cost sharing, family health care burden, and the use of specialty drugs for rheumatoid arthritis. Health Serv Res (2010) 1.27
Disability and health care spending among medicare beneficiaries. Health Aff (Millwood) (2005) 1.26
The value of specialty oncology drugs. Health Serv Res (2009) 1.24
The lifetime burden of chronic disease among the elderly. Health Aff (Millwood) (2005) 1.23
HIV care providers emphasize the importance of the Ryan White Program for access to and quality of care. Health Aff (Millwood) (2014) 1.21
Hospital value-based purchasing. J Hosp Med (2013) 1.21
The effect of medicare health maintenance organizations on hospitalization rates for ambulatory care-sensitive conditions. Med Care (2006) 1.13
An economic evaluation of the war on cancer. J Health Econ (2010) 1.13
The promise of health care cost containment. Health Aff (Millwood) (2007) 1.13
The effect of regulation on pharmaceutical revenues: experience in nineteen countries. Health Aff (Millwood) (2008) 1.13
Undiagnosed disease, especially diabetes, casts doubt on some of reported health 'advantage' of recent Mexican immigrants. Health Aff (Millwood) (2012) 1.08
Exenatide therapy and the risk of pancreatitis and pancreatic cancer in a privately insured population. Diabetes Technol Ther (2012) 1.07
Outcomes of Basic Versus Advanced Life Support for Out-of-Hospital Medical Emergencies. Ann Intern Med (2015) 1.02
The large social value resulting from use of statins warrants steps to improve adherence and broaden treatment. Health Aff (Millwood) (2012) 1.01
Digesting the doughnut hole. J Health Econ (2013) 1.00
Medicare Part D: a successful start with room for improvement. JAMA (2008) 0.99
Medicare part D after 2 years. Am J Manag Care (2009) 0.99
The impact of comparative effectiveness research on health and health care spending. J Health Econ (2011) 0.98
The Disability burden of COPD. COPD (2012) 0.97
Impact of oral nutritional supplementation on hospital outcomes. Am J Manag Care (2013) 0.97
Trends in the earnings of health care professionals in the United States, 1987-2010. JAMA (2012) 0.97
How costly is hospital quality? A revealed-preference approach. J Ind Econ (2011) 0.96
Identifying potential health care innovations for the future elderly. Health Aff (Millwood) (2005) 0.96
The potential impact of comparative effectiveness research on U.S. health care expenditures. Demography (2010) 0.93
The prospect of a generation free of HIV may be within reach if the right policy decisions are made. Health Aff (Millwood) (2014) 0.92
The pragmatist's guide to comparative effectiveness research. J Econ Perspect (2011) 0.92
Physician prescribing behavior and its impact on patient-level outcomes. Am J Manag Care (2011) 0.91
Predicting new diagnoses of HIV infection using internet search engine data. Clin Infect Dis (2013) 0.91
Nearly 60,000 uninsured and low-income people with HIV/AIDS live in states that are not expanding Medicaid. Health Aff (Millwood) (2014) 0.90
The changing face of pharmacy benefit design. Health Aff (Millwood) (2004) 0.90
Technological advances in cancer and future spending by the elderly. Health Aff (Millwood) (2005) 0.90
Data-driven decision-making tools to improve public resource allocation for care and prevention of HIV/AIDS. Health Aff (Millwood) (2014) 0.90
The effect of HMOs on the inpatient utilization of medicare beneficiaries. Health Serv Res (2004) 0.90
Medicaid cost control measures aimed at second-generation antipsychotics led to less use of all antipsychotics. Health Aff (Millwood) (2011) 0.89
Defense costs of medical malpractice claims. N Engl J Med (2012) 0.89
Guidance for structuring team-based incentives in healthcare. Am J Manag Care (2013) 0.89
Reducing Diagnostic Errors--Why Now? N Engl J Med (2015) 0.89
Disability forecasts and future Medicare costs. Front Health Policy Res (2004) 0.88
The economics of intense exercise. J Health Econ (2010) 0.87
Racial and ethnic disparities in hospital care resulting from air pollution in excess of federal standards. Soc Sci Med (2011) 0.86
Hospital costs and inpatient mortality among children undergoing surgery for congenital heart disease. Health Serv Res (2013) 0.86
Inhaled corticosteroids and the risk of pneumonia in Medicare patients with COPD. Curr Med Res Opin (2012) 0.85
Early HIV treatment in the United States prevented nearly 13,500 infections per year during 1996-2009. Health Aff (Millwood) (2014) 0.85
Coverage and preventive screening. Health Serv Res (2010) 0.85
Inpatient utilization by dual Medicare-Medicaid eligibles in Medicare risk HMOs and fee for service, California, 1991-1996. Manag Care Interface (2004) 0.84
Association between the birth of twins and parental divorce. Obstet Gynecol (2011) 0.83
Diabetes management for low-income patients in Los Angeles: two strategies improved disease control in the short term. Health Aff (Millwood) (2012) 0.83
Effect of disease management on prescription drug treatment: what is the right quality measure? Dis Manag (2007) 0.82
The value of medical and pharmaceutical interventions for reducing obesity. J Health Econ (2012) 0.82
Effect of hospital use of oral nutritional supplementation on length of stay, hospital cost, and 30-day readmissions among Medicare patients with COPD. Chest (2015) 0.81
Measuring the value of better diabetes management. Am J Manag Care (2013) 0.81
Prescription medication abuse and illegitimate internet-based pharmacies. Ann Intern Med (2011) 0.81
Postinterview communication between military residency applicants and training programs. Mil Med (2012) 0.81
A socioeconomic profile of older adults with HIV. J Health Care Poor Underserved (2005) 0.80
Early HIV treatment led to life expectancy gains valued at $80 billion for people infected in 1996-2009. Health Aff (Millwood) (2014) 0.80
An economic analysis of conservative management versus active treatment for men with localized prostate cancer. J Natl Cancer Inst Monogr (2012) 0.79
Did Medicare Part D reduce disparities? Am J Manag Care (2015) 0.79
Formulary restrictions on atypical antipsychotics: impact on costs for patients with schizophrenia and bipolar disorder in Medicaid. Am J Manag Care (2014) 0.78
Drug costs and out-of-pocket spending in cancer clinical trials. Contemp Clin Trials (2007) 0.78
Do Statins Reduce the Health and Health Care Costs of Obesity? Pharmacoeconomics (2015) 0.78
Falsification end points for observational studies--reply. JAMA (2013) 0.77
Survey results show that adults are willing to pay higher insurance premiums for generous coverage of specialty drugs. Health Aff (Millwood) (2012) 0.77
Medication adherence and measures of health plan quality. Am J Manag Care (2015) 0.77
Balancing disease eradication with the emergence of multidrug-resistant HIV in test-and-treat policies. Clin Infect Dis (2013) 0.76
A new method for determining patient payments for outpatient drugs. Am J Manag Care (2002) 0.75
Striking a balance on new technology. Cost-effectiveness analysis can help sort out emerging health care technologies, but what are the consequences for continued medical innovation? AHIP Cover (2006) 0.75
Duty hour reforms in Europe and the United States--reply. JAMA (2013) 0.75